Citation Impact
Citing Papers
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
2008
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
THYMIC DEPENDENCE OF LOSS OF TOLERANCE IN MIXED ALLOGENEIC BONE MARROW CHIMERAS AFTER DEPLETION OF DONOR ANTIGEN
1996
Thiazolidinediones
2004 Standout
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
2018
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
2008 StandoutNature
A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
1999 Standout
Delayed graft function in kidney transplantation
2004 Standout
Hepatitis C and liver transplantation
2005 Nature
Body Fatness and Cancer — Viewpoint of the IARC Working Group
2016 Standout
New Era of Liver Transplantation for Hepatitis B
2002
Hepatocellular carcinoma
2018 Standout
The role of the graft in establishing tolerance
2002
Obesity, inflammation, and liver cancer
2011
DISCORDANT ORGAN XENOTRANSPLANTATION IN PRIMATES
1998
Antitumor Necrosis Factor Therapy for Inflammatory Bowel Disease: A Review of Agents, Pharmacology, Clinical Results, and Safety
1999
Steatosis: Co-factor in Other Liver Diseases *
2005
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
2004
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies
2012
Mixed chimerism and tolerance without whole body irradiation in a large animal model
2000
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 Standout
Hepatocellular carcinoma
2012 Standout
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Non-alcoholic fatty liver disease: The mist gradually clears
2008
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
2007
SIX-YEAR CLINICAL EFFECT OF DONOR BONE MARROW INFUSIONS IN RENAL TRANSPLANT PATIENTS1
2001
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
2016
Acute Renal Failure
1996 Standout
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation
2009 StandoutNobel
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
The metabolic syndrome
2005 Standout
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Non-alcoholic fatty liver disease
2021 Standout
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
2010
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro Analyses
2006
CD154 Blockade for Induction of Mixed Chimerism and Prolonged Renal Allograft Survival in Nonhuman Primates
2004
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies
2007
Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis
2008
Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma
2004
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
MIXED CHIMERISM AS AN APPROACH FOR THE INDUCTION OF TRANSPLANTATION TOLERANCE1
1999
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
COMBINED HISTOCOMPATIBILITY LEUKOCYTE ANTIGENMATCHED DONOR BONE MARROW AND RENAL TRANSPLANTATION FOR MULTIPLE MYELOMA WITH END STAGE RENAL DISEASE: THE INDUCTION OF ALLOGRAFT TOLERANCE THROUGH MIXED LYMPHOHEMATOPOIETIC CHIMERISM
1999
LONG-TERM OUTCOME AND ALLOANTIBODY PRODUCTION IN A NON-MYELOABLATIVE REGIMEN FOR INDUCTION OF RENAL ALLOGRAFT TOLERANCE1
1999
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
NASH and HCC
2009
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
In Search of the Elusive Holy Grail: the Mechanisms and Prospects for Achieving Clinical Transplantation Tolerance
2001
The renal allograft biopsy
1996
Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation
1999
Infection in Solid-Organ Transplant Recipients
2007 Standout
Derivation of Functional Antagonists Using N-Terminal Extracellular Domain of Gonadotropin and Thyrotropin Receptors
1997 StandoutNobel
The Prevalence and Etiology of Elevated Aminotransferase Levels in The United States
2003
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Hepatocellular Carcinoma
2011 Standout
Depletion of CD8 Memory T Cells for Induction of Tolerance of a Previously Transplanted Kidney Allograft
2007
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
MODIFICATIONS OF THE CONDITIONING REGIMEN FOR ACHIEVING MIXED CHIMERISM AND DONOR-SPECIFIC TOLERANCE IN CYNOMOLGUS MONKEYS1
1997
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Anemia of Chronic Disease
2005 Standout
The role of immunosuppression in recurrence of hepatitis C
2003
Tolerance to vascularized organ allografts in large-animal models
1999
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
2015
Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway
2008 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Surveillance for Hepatocellular Carcinoma in Patients with NASH
2016
CD4+ Regulatory T Cells Are Spared from Deletion by Antilymphocyte Serum, a Polyclonal Anti-T Cell Antibody
2006
Induction Of Kidney Allograft Tolerance After Transient Lymphohematopoietic Chimerism In Patients With Multiple Myeloma And End-Stage Renal Disease1
2002
Activation of Orphan Receptors by the Hormone Relaxin
2002 StandoutScience
Effects of Excess Weight on Cancer Incidences Depending on Cancer Sites and Histologic Findings Among Men: Korea National Health Insurance Corporation Study
2005
The Danger Model: A Renewed Sense of Self
2002 StandoutScience
Alloantigen–induced specific immunological unresponsiveness
2001
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
2003 Standout
CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
1997
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Production of α-1,3-Galactosyltransferase Knockout Pigs by Nuclear Transfer Cloning
2002 StandoutScience
Nonalcoholic Fatty Liver Disease
2015 Standout
Analysis of the Underlying Cellular Mechanisms of Anti-CD154-Induced Graft Tolerance: The Interplay of Clonal Anergy and Immune Regulation
2005 StandoutNobel
Obesity-Associated Liver Disease
2008
Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein
1997
Works of James D. Eason being referenced
EVALUATION OF RECOMBINANT HUMAN SOLUBLE DIMERIC TUMOR NECROSIS FACTOR RECEPTOR FOR PREVENTION OF OKT3-ASSOCIATED ACUTE CLINICAL SYNDROME1,2
1996
Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1
2003
BIOLOGICAL EFFECTS AND FATE OF A SOLUBLE, DIMERIC, 80-kDa TUMOR NECROSIS FACTOR RECEPTOR IN RENAL TRANSPLANT RECIPIENTS WHO RECEIVE OKT3 THERAPY1
1997
Tolerance: Is It Worth the Risk?
2005
Steroid-free liver transplantation using rabbit antithymocyte globulin induction: Results of a prospective randomized trial
2001
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
2002
Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus Monkeys
1995
Inhibition Of The Effects Of Tnf In Renal Allograft Recipients Using Recombinant Human Dimeric Tumor Necrosis Factor Receptors
1995
SHOULD LIVER TRANSPLANTATION BE PERFORMED FOR PATIENTS WITH HEPATITIS B?
1994
Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus Monkeys
1995